Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial - The Lancet
Bodily Lactation Latte 2-Pack: a delicious alternative to lactation cookies